Angiotech Pharmaceuticals Inc. develops, manufactures, and markets medical device products and technologies primarily in the areas of dental surgery, dermatology, electrophysiology, gynecology, laparoscopic surgery, microsurgery, ophthalmic surgery, orthopedic surgery, plastic surgery, and urology. Its products include Quill knotless tissue-closure device, BioSentry tract sealant system, The Sharpoint Solo I/A Handpiece, Sharpoint PLUS, Sharpoint microsutures, Sharpoint Ophthalmic sutures, LOOK sutures, Sharpoint SOLO single-use instruments, Sharpoint microsurgical knives, Sharpoint Trephines, Sharpoint UltraPlug Punctal Plugs, Sharpoint UltraPlug Evaluation and Insertion Products, Surgical Specialties Animal Health Sutures, and Surgical Specialties Bone Wax. The company was formerly known as Angiogenesis Technologies, Inc. and changed its name to Angiotech Pharmaceuticals Inc. in 1996. Angiotech Pharmaceuticals Inc. was founded in 1989 and is headquartered in Vancouver, Canada.